1chartz M-compressed

Seven stocks that delivered blowout earnings in Q2

Equities 2 minutes to read
Neil Wilson
Neil Wilson

Investor Content Strategist

Note: This is marketing material. This article is not investment advice, capital is at risk.

1. Sea Ltd

  • Performance: Earnings jumped by 364% YoY to $0.65/share (beat $0.64 est.), revenue up 38% to $5.26 billion.

  • Why it stands out: Strongest sales growth in years; stock surged ~20%. Sea started as a gaming business but now runs Singapore-based Shopee, the largest e-commerce platform in Southeast Asia.

2. Duolingo

  • Performance: Subscription revenue +46%, overall revenue +41%, record net income, improved full-year guidance; gross margin up to 72.4%.

  • Why it stands out: AI-driven margin improvement but it’s a double-edged sword. the stock rallied 30% after it reported its earnings last week, but the share price is now lower than prior to the update, due to ChatGPT developer OpenAI showing off its newly launched GPT-5 AI

3. Pfizer

  • Performance: EPS of $0.78 beat $0.58 estimate, revenue of $14.65 billion beat ~$13.56 billion estimate.

  • Why it stands out: Raised full-year guidance, strong demand for Covid-related products and Padcev, a cancer treatment acquired with Seagen. Visibility on the pipeline now key as Covid retreats into the past.

4. AMC Entertainment

  • Performance: Revenue rose 35% to $1.4 billion, adjusted EBITDA soared 391.4% to $189 million, net loss narrowed to just 1 cent per share.

  • Why it stands out: Massive operational recovery with a 26% increase in moviegoers’ attendance compared to last year. One of the original meme stocks from 2021.

5. Palantir Technologies

  • Performance: AI and data analytics company reported Q2 revenue rose 48% to >$1 billion and beat, plus raised full‑year guidance.

  • Why it stands out: Reckoned to be perhaps the most overvalued company on the S&P 500 but keeps delivering results. Pentagon contracts still vital but also now seeing huge growth in US commercial market.

6. Axon Enterprise

  • Performance: Sales climbed 33% to $669 million, a beat, while adjusted earnings of $2.12 a share surpassed the consensus estimate of $1.45 a share. Recurring revenues rose 39%.

  • Why it stands out: Stock surged ~16% after the Taser manufacturer hiked its full-year outlook but have since retraced all the gains. Multiple analysts raised price targets – drones, robotics and AI are areas where it might grow.

7. BWX Technologies

  • Performance: Beat earnings and revenue forecasts.

  • Why it stands out: Stock up 28% in the last month, company is benefitting from soaring demand for naval nuclear power systems and next-generation reactors. BofA Securities raised its price target on the stock to $220 from $155, citing a record $6 billion backlog and long-term growth prospects in defence, commercial energy, and space sectors. If NASA does build a nuclear reactor on the Moon, BWX could be the winner.

 

 

 

 

 

Quarterly Outlook

01 /

  • Q3 Investor Outlook: Beyond American shores – why diversification is your strongest ally

    Quarterly Outlook

    Q3 Investor Outlook: Beyond American shores – why diversification is your strongest ally

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Q3 Macro Outlook: Less chaos, and hopefully a bit more clarity

    Quarterly Outlook

    Q3 Macro Outlook: Less chaos, and hopefully a bit more clarity

    John J. Hardy

    Global Head of Macro Strategy

    After the chaos of Q2, the quarter ahead should get a bit more clarity on how Trump 2.0 is impacting...
  • Equity outlook: The high cost of global fragmentation for US portfolios

    Quarterly Outlook

    Equity outlook: The high cost of global fragmentation for US portfolios

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: Commodities rally despite global uncertainty

    Quarterly Outlook

    Commodity Outlook: Commodities rally despite global uncertainty

    Ole Hansen

    Head of Commodity Strategy

  • Upending the global order at blinding speed

    Quarterly Outlook

    Upending the global order at blinding speed

    John J. Hardy

    Global Head of Macro Strategy

    We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
  • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Quarterly Outlook

    Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

  • China Outlook: The choice between retaliation or de-escalation

    Quarterly Outlook

    China Outlook: The choice between retaliation or de-escalation

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: A bumpy road ahead calls for diversification

    Quarterly Outlook

    Commodity Outlook: A bumpy road ahead calls for diversification

    Ole Hansen

    Head of Commodity Strategy

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Markets UK Ltd. (Saxo) and the Saxo Bank Group provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice nor a recommendation. Access and use of this website is subject to: (i) the Terms of Use; (ii) the full Disclaimer; (iii) the Risk Warning; and (iv) any other notice or terms applying to Saxo’s news and research.

Saxo’s content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer for more details. Past Performance is not indicative of future results.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992